Back
Viking Therapeutics Stock Price Chart

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
32
VKTX
Viking Therapeutics
Last Price:
$27.00
Seasonality Move:
4.06%
7 Day Trial
ALL ACCESS PASS
$
7

Notable investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
The current trend is relatively stagnant and VKTX is experiencing slight buying pressure.
Viking Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.59 | Buy |
20-day SMA: | 27.13 | Buy |
50-day SMA: | 27 | Buy |
200-day SMA: | 40.91 | Sell |
8-day EMA: | 26.98 | Buy |
20-day EMA: | 27.05 | Buy |
50-day EMA: | 27.36 | Buy |
200-day EMA: | 35.95 | Sell |
Viking Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 55.12 | Buy |
Chaikin Money Flow: | 1072308 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.2 - 28.12) | Buy |
Bollinger Bands (100): | (24.9 - 30.3) | Buy |
Viking Therapeutics Technical Analysis
Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 28.17 while VKTX 8-day simple moving average is 26.59, which is a Buy signal.
-
The stock price of VKTX is 28.17 while Viking Therapeutics 20-day SMA is 27.13, which makes it a Buy.
-
Viking Therapeutics 50-day simple moving average is 27.00 while VKTX share price is 28.17, making it a Buy technically.
-
VKTX stock price is 28.17 and Viking Therapeutics 200-day simple moving average is 40.91, creating a Sell signal.
VKTX Technical Analysis vs Fundamental Analysis
Sell
32
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a SellThe current Viking Therapeutics [VKTX] share price is $28.17. The Score for VKTX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Viking Therapeutics Stock Info
Market Cap:
3.2B
Price in USD:
28.17
Share Volume:
5.4M
Viking Therapeutics 52-Week Range
52-Week High:
81.73
52-Week Low:
18.92
Sell
32
Viking Therapeutics (VKTX)
is a Sell
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?The Viking Therapeutics stock price is 28.17 USD today.
-
Will VKTX stock go up or go down?Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Viking Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is overvalued.
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 28.17 while VKTX 8-day exponential moving average is 26.98, which is a Buy signal.
-
The stock price of VKTX is 28.17 while Viking Therapeutics 20-day EMA is 27.05, which makes it a Buy.
-
Viking Therapeutics 50-day exponential moving average is 27.36 while VKTX share price is 28.17, making it a Buy technically.
-
VKTX stock price is 28.17 and Viking Therapeutics 200-day simple moving average is 35.95, creating a Sell signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.23 per share, a decrease this year of $0.88 per share, and a decrease next year of $0.64 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
-
VKTX Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Viking Therapeutics is a Sell
-
Viking Therapeutics Relative Strength Index (RSI) is 55.12, which suggest Viking Therapeutics is overbought
-
The Bollinger Bands (25) for Viking Therapeutics is (26.2 - 28.12), which suggest Viking Therapeutics is a Buy
-
The Bollinger Bands (100) for Viking Therapeutics is (24.9 - 30.3), which suggest Viking Therapeutics is a Buy
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.